Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve The Unaudited Financial Results ....
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India Ltd has informed BSE that its Board of Directors will meet on Wednesday, January 28, 2026, to consider and approve the Unaudited Financial Results for the quarter ended December 31, 2025 (Q3 FY26). This is a standard regulatory filing under SEBI Listing Regulations. The company has also declared a trading window closure from January 1, 2026, until 48 hours after the results are announced, in line with insider trading norms.
This is a routine advance intimation with no direct impact on shareholders or stock price. Investors should watch for the actual results on January 28, 2026, for any meaningful performance updates or guidance.